Contact Us
Subscribe
e-Edition

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

55°
- Middle Point, OH (45863)
  Today
  
  Considerable cloudiness with occasional rain showers. High 56F. Winds WNW at 10 to 15 mph. Chance of rain 40%..
  
  Tonight
  
  Overcast. Low 39F. Winds NW at 5 to 10 mph.
  
  Updated: May 6, 2026 @ 1:53 pm
- Full Forecast

Site search

Home
News
- Local News
Sports
Obituaries
Local Events
Photos
e-Edition
Classifieds

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Aligos Therapeutics, Inc. - Common stock (NQ:ALGS)

6.380 +0.030 (+0.47%)

Streaming Delayed Price Updated: 2:06 PM EDT, May 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Aligos Therapeutics, Inc. - Common stock

< Previous 1 2 3 4 5 6 7 8 Next >

Aligos Pulls Plug On Early-Stage Chronic Hepatitis B Treatment Candidate ↗

March 22, 2022

Aligos Therapeutics Inc (NASDAQ: ALGS) has

Via Benzinga

Recap: Aligos Therapeutics Q4 Earnings ↗

March 10, 2022

Aligos Therapeutics (NASDAQ:ALGS) reported its Q4 earnings results on Thursday, March 10, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings...

Via Benzinga

Earnings Scheduled For March 10, 2022 ↗

March 10, 2022

Companies Reporting Before The Bell • Despegar.com (NYSE:DESP) is expected to report quarterly loss at $0.08 per share on revenue of $110.93 million. • ProShares...

Via Benzinga

Aligos Therapeutics Earnings Preview ↗

March 09, 2022

Aligos Therapeutics (NASDAQ:ALGS) is set to give its latest quarterly earnings report on Thursday, 2022-03-10. Here's what investors need to know before the announcement. Analysts...

Via Benzinga

10 Biggest Price Target Changes For Wednesday ↗

February 16, 2022

Needham raised Airbnb, Inc. (NASDAQ: ABNB) price target from $210 to $220. Airbnb shares rose 3.1% to $185.70 in pre-market trading.

Via Benzinga

Can Anyone Challenge Pfizer's Covid Dominance? Why These Biotechs Say Yes ↗

February 11, 2022

Drug behemoth Pfizer was the first to launch a Covid antiviral pill — but a pack of small biotech stocks are already nipping at its heels.

Via Investor's Business Daily

The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO ↗

August 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (...

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

February 17, 2022

On Thursday, 147 companies achieved new lows for the year. Significant Points From Today's 52-Week Lows: PayPal Holdings (NASDAQ:PYPL) was the biggest company...

Via Benzinga

SHAREHOLDER ALERT: Robbins LLP Investigates Aligos Therapeutics, Inc. (ALGS) on Behalf of Shareholders

January 28, 2022

From Robbins LLP

Via Business Wire

NASDAQ: ALGS Shareholder Notice: Investigation over Potential Securities Laws Violations by Aligos Therapeutics, Inc. ↗

January 24, 2022

San Diego, CA -- (SBWIRE) -- 01/24/2022 -- An investigation for investors in Aligos Therapeutics, Inc. (NASDAQ: ALGS) shares over potential securities laws violations by Aligos Therapeutics, Inc. was...

Via SBWire

ALIGOS ALERT: Bragar Eagel & Squire, P.C. is Investigating Aligos Therapeutics, Inc. on Behalf of Aligos Stockholders and Encourages Investors to Contact the Firm

January 21, 2022

From Bragar Eagel & Squire, P.C.

Via Business Wire

SHAREHOLDER ALERT: Robbins LLP Investigates Aligos Therapeutics, Inc. (ALGS) on Behalf of Shareholders

January 20, 2022

From Robbins LLP

Via Business Wire

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

January 11, 2022

Gainers Black Diamond Therapeutic (NASDAQ:BDTX) stock increased by 18.2% to $5.32 during Tuesday's pre-market session. The market value of their outstanding shares is...

Via Benzinga

The Week Ahead In Biotech (Jan 10-15): JPMorgan Healthcare Conference Front And Center, Preannouncements Keep Coming ↗

January 10, 2022

Biotech stocks came under selling pressure along with the broader market, as rate hike fears seized Wall Street. The news flow, however, was scanty. Last week, the Food and Drug...

Via Benzinga

56 Biggest Movers From Friday ↗

January 10, 2022

Gainers Hour Loop, Inc. (NASDAQ: HOUR) shares jumped 99.8% to $7.99 after the company priced its IPO at $4 per share. China HGS Real Estate Inc. (NASDAQ: HGSH) shares...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

January 07, 2022

Gainers Absci (NASDAQ:ABSI) stock increased by 28.2% to $7.87 during Friday's regular session. As of 12:30 EST, Absci's stock is trading at a volume of 38.6...

Via Benzinga

33 Stocks Moving In Friday's Mid-Day Session ↗

January 07, 2022

Gainers Marin Software Incorporated (NASDAQ: MRIN) shares climbed 35.9% to $4.6899 after the company announced an integration with Amazon Ads' demand-side platform. Absci...

Via Benzinga

Mid-Afternoon Market Update: Gold Drops 2%; Berkeley Lights Shares Plummet ↗

January 06, 2022

Toward the end of trading Thursday, the Dow traded down 0.35% to 36,278.43 while the NASDAQ rose 0.22% to 15,133.94. The S&P also rose 0.14% to 4,707.37. The U.S. has the...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

January 06, 2022

Gainers Eargo (NASDAQ:EAR) stock increased by 50.0% to $6.84 during Thursday's regular session. The current volume of 90.4 million shares is 5474.6% of Eargo's...

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

January 07, 2022

Before 10 am on Friday, 110 companies set new 52-week lows. Interesting Points From Today's 52-Week Lows: Humana (NYSE:HUM) was the biggest company on a market cap...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 7, 2022 ↗

January 07, 2022

Upgrades According to Wolfe Research, the prior rating for CVR Energy Inc (NYSE:

Via Benzinga

58 Biggest Movers From Yesterday ↗

January 07, 2022

Gainers Eargo, Inc. (NASDAQ: EAR) shares climbed 59.7% to close at $7.28 on Thurs after the company announced the Department of Justice confirmed to it that the previously-...

Via Benzinga

Mid-Day Market Update: Nasdaq Turns Higher; Vocera Communications Shares Surge ↗

January 06, 2022

Midway through trading Thursday, the Dow traded down 0.34% to 36,284.59 while the NASDAQ rose 0.18% to 15,127.00. The S&P, however, rose 0.07% to 4,703.93. The U.S. has the...

Via Benzinga

33 Stocks Moving In Thursday's Mid-Day Session ↗

January 06, 2022

Gainers Eargo, Inc. (NASDAQ: EAR) shares jumped 50.8% to $6.88 after the company announced the Department of Justice confirmed to it that the previously-announced criminal probe...

Via Benzinga

Mid-Morning Market Update: Markets Open Lower; Walgreens Tops Q1 Views ↗

January 06, 2022

Following the market opening Thursday, the Dow traded down 0.52% to 36,217.32 while the NASDAQ fell 1.09% to 14,935.90. The S&P also fell, dropping 0.52% to 4,676.00. The U.S...

Via Benzinga

The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More ↗

November 08, 2021

Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out...

Via Benzinga

The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO ↗

November 04, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &...

Via Benzinga

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline ↗

October 31, 2021

Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2021 ↗

September 09, 2021

Upgrades According to Benchmark, the prior rating for TopBuild Corp (NYSE:

Via Benzinga

The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs ↗

August 01, 2021

Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results....

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

News
Announcements
Sports
Entertainment
Local Events
Obituaries
Photos
Videos
Online Features

Services

Subscription Services
Submission Forms
Classifieds
Place an Ad
Promote Your Event
Email Alerts
Search
Weather

minstercommunitypost.com
PO Box 155
Minster, OH 45863
Phone: 419-300-1076
Email: editor@minstercommunitypost.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Middle Point, OH (45863)

Today

Tonight

Aligos Therapeutics, Inc. - Common stock (NQ:ALGS)

All News about Aligos Therapeutics, Inc. - Common stock

Sections

Services